What does PHARMAKAISER GRIVEGNEE do?

PHARMAKAISER GRIVEGNEE is a pharmacy in Liège. Private Limited, started on 17 September 2021, 1 establishment.

What is the address of PHARMAKAISER GRIVEGNEE?

The registered office of PHARMAKAISER GRIVEGNEE is located at Rue Fraischamps 24, 4030 Liège.

Is PHARMAKAISER GRIVEGNEE still active?

Yes. According to the CBE (4 October 2026) PHARMAKAISER GRIVEGNEE is active, legal situation “Normale toestand”, started on 17 September 2021.

Is PHARMAKAISER GRIVEGNEE registered on Peppol?

Yes, PHARMAKAISER GRIVEGNEE is registered on the Peppol network with ID 0208:0774285474.

What is the enterprise number of PHARMAKAISER GRIVEGNEE?

The enterprise number of PHARMAKAISER GRIVEGNEE is BE0774285474.

When was PHARMAKAISER GRIVEGNEE founded?

PHARMAKAISER GRIVEGNEE was founded on 17 September 2021.

Who are the directors of PHARMAKAISER GRIVEGNEE?

According to the 2025 annual accounts, the directors of PHARMAKAISER GRIVEGNEE are: Audrey Kaiser Management SRL, Anne-Sophie Kaiser Gestion SRL.

Is PHARMAKAISER GRIVEGNEE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 September 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMAKAISER GRIVEGNEE make in 2025?

PHARMAKAISER GRIVEGNEE recorded a loss after taxes of € 67,727 in financial year 2025.

What is the revenue of PHARMAKAISER GRIVEGNEE?

As a small company, PHARMAKAISER GRIVEGNEE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 217,196.

How much does an employee at PHARMAKAISER GRIVEGNEE earn?

The average wage cost per full-time employee at PHARMAKAISER GRIVEGNEE was € 68,000 in 2025: staff costs of € 203,976 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMAKAISER GRIVEGNEE have?

According to the 2025 annual accounts, PHARMAKAISER GRIVEGNEE has 3 full-time equivalents (FTE).

PHARMAKAISER GRIVEGNEE (Private Limited) - Liège

Dossier PHARMAKAISER GRIVEGNEE, printed on 4 October 2026 from databakkes.be/en/0774285474/pharmakaiser-grivegnee. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

PHARMAKAISER GRIVEGNEE from Liège, company number BE0774285474, closed financial year 2025 with a result of € -67,727 after tax. For that financial year PHARMAKAISER GRIVEGNEE recorded a gross margin of € 217,196 and equity of € 260,961. Compared with financial year 2024, the result moved from € -4,245 to € -67,727. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 260,961

▼ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -67,727

▼ 1495 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 48,085

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 84,686.

People and assets in 2025

Full-time equivalents

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 203,976

▲ 19% vs 2024

€ 68,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 126,614

▲ € 125,846 vs 2024

Of which on lease € 126,205.

Debts at end 2025

Bank debt ≈ 21 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 773,342

▲ € 641,255 vs 2024

€ 37,344 is repaid this year. At this pace the long-term loan is gone in ≈ 21 years.

Owed to suppliers

€ 116,834

▲ 90% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 29,152

▲ 32% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 442,032 Gross margin 2022: € 442,032 First fiscal year in the series	€ 230,068 Gross margin 2023: € 230,068 ▼ 48% vs 2022 (€ 442,032) Unfavourable step	€ 195,713 Gross margin 2024: € 195,713 ▼ 15% vs 2023 (€ 230,068) Unfavourable step	€ 217,196 Gross margin 2025: € 217,196 ▲ 11% vs 2024 (€ 195,713) Favourable step	▲ 11%
Profit after taxes	€ 12,710 Profit after taxes 2022: € 12,710 First fiscal year in the series	€ 15,244 Profit after taxes 2023: € 15,244 ▲ 20% vs 2022 (€ 12,710) Favourable step	€ -4,245 Profit after taxes 2024: € -4,245 ▼ € 19,489 vs 2023 (€ 15,244) Unfavourable step	€ -67,727 Profit after taxes 2025: € -67,727 ▼ € 63,481 vs 2024 (€ -4,245) Unfavourable step	▼ € 63,481
Equity	€ 317,689 Equity 2022: € 317,689 First fiscal year in the series	€ 332,933 Equity 2023: € 332,933 ▲ 5% vs 2022 (€ 317,689) Favourable step	€ 328,687 Equity 2024: € 328,687 ▼ 1% vs 2023 (€ 332,933) Unfavourable step	€ 260,961 Equity 2025: € 260,961 ▼ 21% vs 2024 (€ 328,687) Unfavourable step	▼ 21%
Total debts	€ 252,524 Total debts 2022: € 252,524 First fiscal year in the series	€ 234,097 Total debts 2023: € 234,097 ▼ 7% vs 2022 (€ 252,524) Favourable step	€ 218,106 Total debts 2024: € 218,106 ▼ 7% vs 2023 (€ 234,097) Favourable step	€ 947,663 Total debts 2025: € 947,663 ▲ € 729,557 vs 2024 (€ 218,106) Unfavourable step	▲ € 729,557
Cash	€ 83,990 Cash 2022: € 83,990 First fiscal year in the series	€ 96,923 Cash 2023: € 96,923 ▲ 15% vs 2022 (€ 83,990) Favourable step	€ 77,996 Cash 2024: € 77,996 ▼ 20% vs 2023 (€ 96,923) Unfavourable step	€ 48,085 Cash 2025: € 48,085 ▼ 38% vs 2024 (€ 77,996) Unfavourable step	▼ 38%
Land & buildings	€ 197,311 Land & buildings 2022: € 197,311 First fiscal year in the series	€ 186,636 Land & buildings 2023: € 186,636 ▼ 5% vs 2022 (€ 197,311) Unchanged	€ 175,962 Land & buildings 2024: € 175,962 ▼ 6% vs 2023 (€ 186,636) Unchanged	€ 617,754 Land & buildings 2025: € 617,754 ▲ 251% vs 2024 (€ 175,962) Unchanged	▲ 251%
Retained profit	€ 141,414 Retained profit 2022: € 141,414 First fiscal year in the series	€ 156,658 Retained profit 2023: € 156,658 ▲ 11% vs 2022 (€ 141,414) Favourable step	€ 152,412 Retained profit 2024: € 152,412 ▼ 3% vs 2023 (€ 156,658) Unfavourable step	€ 84,686 Retained profit 2025: € 84,686 ▼ 44% vs 2024 (€ 152,412) Unfavourable step	▼ 44%
Bank debt	€ 149,727 Bank debt 2022: € 149,727 First fiscal year in the series	€ 140,981 Bank debt 2023: € 140,981 ▼ 6% vs 2022 (€ 149,727) Favourable step	€ 132,087 Bank debt 2024: € 132,087 ▼ 6% vs 2023 (€ 140,981) Favourable step	€ 773,342 Bank debt 2025: € 773,342 ▲ € 641,255 vs 2024 (€ 132,087) Unfavourable step	▲ € 641,255
Balance sheet total	€ 570,212 Balance sheet total 2022: € 570,212 First fiscal year in the series	€ 567,030 Balance sheet total 2023: € 567,030 ▼ 1% vs 2022 (€ 570,212) Unchanged	€ 546,793 Balance sheet total 2024: € 546,793 ▼ 4% vs 2023 (€ 567,030) Unchanged	€ 1,208,623 Balance sheet total 2025: € 1,208,623 ▲ 121% vs 2024 (€ 546,793) Unchanged	▲ 121%
Employees (FTE)	3.2 Employees (FTE) 2022: 3.2 First fiscal year in the series	2.8 Employees (FTE) 2023: 2.8 ▼ 0.4 vs 2022 (3.2) Unchanged	2.4 Employees (FTE) 2024: 2.4 ▼ 0.4 vs 2023 (2.8) Unchanged	3 Employees (FTE) 2025: 3 ▲ 0.6 vs 2024 (2.4) Unchanged	▲ 0.6

Key figures of PHARMAKAISER GRIVEGNEE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMAKAISER GRIVEGNEE?

What happened at PHARMAKAISER GRIVEGNEE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 67,727. filed late Source: NBB ↗
Sep 17, 2021 New establishment in Liège. KBO
2021 Audrey Kaiser Management SRL became a director. NBB
2021 Anne-Sophie Kaiser Gestion SRL became a director. NBB
Sep 17, 2021 Start of the company according to the CBE. KBO

In short

From € 12,710 profit in 2022 to € 67,727 loss in 2025.

Paid € 294 in corporate taxes since 2022.

Best year ever: 2023, with € 15,244 profit.

On average € 72,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMAKAISER GRIVEGNEE? We notify you, reason included.

Follow PHARMAKAISER GRIVEGNEE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ANNE-SOPHIE KAISER GESTION 50%

AUDREY KAISER MANAGEMENT 50%

The stake of ANNE-SOPHIE KAISER GESTION, AUDREY KAISER MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMAKAISER GRIVEGNEE

Behind PHARMAKAISER GRIVEGNEE are Audrey Kaiser Management SRL and Anne-Sophie Kaiser Gestion SRL. The shares are held by ANNE-SOPHIE KAISER GESTION (50%) and AUDREY KAISER MANAGEMENT (50%).

See the full network in the app

Directors

According to the 2025 annual accounts

Audrey Kaiser Management SRL

Director · represented by Audrey Kaiser

since 2021

Anne-Sophie Kaiser Gestion SRL

Director · represented by Anne-Sophie Kaiser

Also active at: PHARMACIE DEMEULDRE - DEGIVE

since 2021

Shareholders

ANNE-SOPHIE KAISER GESTION

50%

AUDREY KAISER MANAGEMENT

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Fraischamps 24

4030 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0774.285.474

VAT number

BE 0774.285.474

Registered office

Rue Fraischamps 24, 4030 Liège

Names & denominations

PHARMAKAISER GRIVEGNEE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 September 2021

Peppol

Active · Active since 11 Dec 2025

Contact

[email protected] +32478595676

Activities · NACE

Detailhandel in farmaceutische producten

Overige niet-gespecialiseerde detailhandel

Vervaardiging van overige farmaceutische producten

Vervaardiging van geneesmiddelen

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel via postorderbedrijven of via internet

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMAKAISER GRIVEGNEE

Warning lights

Financials

What happened to PHARMAKAISER GRIVEGNEE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions